Archive: Tarantula Toxins Offer Key Insights Into Neuroscience of Pain
Researchers have identified a pair of tarantula toxins that target a previously unknown pain pathway in sensory nerves.
University of California San Francisco
Give to UCSF
Displaying 2251 - 2280 of 3310
-
-
Archive: Michael Merzenich Wins 2016 Kavli Prize in Neuroscience
For his pioneering research on plasticity, the brain’s remarkable capacity to modify its structure and function, UCSF's Michael M. Merzenich, PhD, has been awarded the 2016 Kavli Prize in Neuroscience.
-
Archive: Researchers Convert Cirrhosis-Causing Cells to Healthy Liver Cells in Mice
A team of researchers led by UCSF scientists has demonstrated in mice that it is possible to generate healthy new liver cells within the organ itself, making engraftment unnecessary.
-
Archive: Study Provides Insight into Bacterial Resilience and Antibiotic Targets
Researchers at UC San Francisco and Stanford University have performed the first comprehensive survey of the central genes and proteins essential to bacterial life.
-
Archive: Sporadic Steroids May Be as Effective as Daily Dose for Some Preschoolers with Wheezing
Children aged 6 and under with intermittent wheezing triggered by colds may not need to take inhaled steroids on a daily basis to limit the flare-ups that can result in emergency treatment.
-
Archive: A Slight Increase in Pediatric Cancer Risk Seen with Infant Phototherapy
Phototherapy, increasingly used to treat jaundiced infants, could very slightly raise the risk of pediatric cancers, particularly myeloid leukemia, according to epidemiological research published, online Monday, May 23, in Pediatrics.
-
Archive: Deadly Fungus Uses Unexpected System To Control Its Virulence
A research team led by UC San Francisco scientists has discovered a cellular signaling system that regulates the virulence of Cryptococcus neoformans, a fungus that has been estimated to cause nearly a million cases of meningitis worldwide per year, about 625,000 of which are fatal.
-
Archive: Better Survival for Colon Cancer Patients with Left-Sided Tumors
A national study led by a UCSF oncologist has found that patients with metastatic colon cancer that develops on the left side of the colon survive significantly longer than those with cancer that develops on the right side.
-
Archive: Graduate Division Publishes Call to Action on Tracking Postdoc Career Outcomes
The UCSF Graduate Division has published the first comprehensive study of career outcomes for UCSF’s postdoctoral scholars and possibly the largest single-institution study on the subject conducted to date.
-
Archive: Hybrid Cancer Drug Could Be Resistance-Resistant
A team of cancer researchers led by scientists at UCSF and Memorial Sloan Kettering Cancer Center in New York have developed a first-of-its-kind hybrid drug with the power to outsmart drug-resistant cancers.
-
Archive: If You Get Colon Cancer, Your Prognosis Depends Partly On Where It Started
-
Archive: UCSF Researchers Reappraise Treatment for Belly Birth Defect
UC San Francisco researchers have shed light on how the immune system of a fetus can run amok, triggering inflammation in the developing intestines that protrude outside of the body through a hole beside the belly button.
-
Archive: Many Consumer Telemedicine Sites Put Skin Disease Patients at Risk, Says UCSF Dermatologist
Direct-to-consumer commercial telemedicine sites remotely treating patients for skin disease engaged in practices that put patients’ health and safety at risk.
-
Archive: NIH Grant to Support Study on Possible Fractures from Osteoporosis Drugs
UCSF has received a four-year, $2.4 million National Institutes of Health grant for an international study on the potential of femoral fractures from osteoporosis drugs.
-
Archive: Most Asthma Research May Not Apply to African-American Children
Results from the largest single study of the genetic and environmental causes of asthma in African-American children suggest that only a tiny fraction of known genetic risk factors for the disease apply to this population, raising concerns for clinicians and scientists working to stem the asthma epidemic among African-Americans.
-
Archive: Lung Disease May Evade Diagnosis in Half of Heavy Smokers, Ex-Smokers
Approximately 50 percent of current and ex-smokers with normal lung function have chronic breathing symptoms and flare-ups that are similar to patients with a disease that is the nation’s third most common killer, according to a multisite study led by UCSF.
-
Archive: Health Care Costs Drop Quickly After Smokers Quit
A new national analysis by UCSF of health care expenditures associated with smoking estimates that a 10 percent decline in smoking in the U.S. would be followed a year later by an estimated $63 billion reduction in total national health care costs.
-
Archive: Decade After QB3’s First Incubator, Lawmaker Wants to Fund More UC Innovation
Ten years after the QB3 Garage incubator launched, the idea has grown an innovation ecosystem and become the catalyst for state legislation that could help turn ideas at UC campuses into job-providing companies.
-
Archive: ‘Inexpensive Old Drug’ May Prevent Brain Damage in High-Risk Newborns, Study Shows
A 27-year-old drug for anemia may protect newborns at high risk for brain damage, according to the results of a multisite trial led by researchers at UCSF.
-
Archive: Crosstalk Between Left and Right Brain Is Key to Language Development
Proper communication between the left and right sides of the brain is critical for the development of advanced language skills, according to new research by UC San Francisco scientists.
-
Archive: Exposure to Poor Neighborhoods Raises Refugees’ Risk of Diabetes
Refugees who fled to Europe a generation ago are significantly more likely to have developed type 2 diabetes if they initially settled in poor neighborhoods, according to a study of 60,000 refugees who came to Sweden between 1987 and 1991.
-
Archive: Bold Innovation Program Fast-Tracks Precision Medicine Research
Exciting advances in medicine and health are being researched in precision medicine projects recently funded by the George and Judy Marcus Program in Precision Medicine Innovation.
-
Archive: Math Points to 100-Times Faster Mapping of Gene Activity
New research by UCSF scientists could accelerate – by 10 to 100-fold – the pace of many efforts to profile gene activity, ranging from basic research into how to build new tissues from stem cells to clinical efforts to detect cancer or auto-immune diseases by profiling single cells in a tiny drop of blood.
-
Wrapping Up Multiple Sclerosis
With one drug to shut down its progression and another to undo its damage, plus a worldwide effort stalking the origins of multiple sclerosis, MS doesn’t stand a chance.
-
Archive: Cytokine Triggers Immune Response at Expense of Blood Renewal
Stem cell biologists at UCSF have demonstrated that IL-1 itself directly transforms the blood system by driving blood stem cells in the bone marrow to switch away from their restorative, rejuvenating role in blood renewal and towards emergency production of immune cells.
-
Archive: Malaria-Free World Possible Within a Generation, Study Says
Global malaria eradication is possible within a generation, but only with renewed focus, new tools and sufficient financial support, according to a paper published in The Lancet by the Global Health Group’s Malaria Elimination Initiative at UCSF.
-
Archive: Brain’s Immune System May Trigger Frontotemporal Dementia
Frontotemporal dementia, the second most common cause of dementia in people under 65, may be triggered by a defect in immune cells called microglia that causes them to consume the brain’s synaptic connections, according to new research led by UCSF scientists.
-
Archive: Gene Mutation Makes Tumors Tense, Worsens Patient Prognosis
UCSF researchers have discovered that the chances of survival for patients with pancreatic adenocarcinoma (PDAC) — the most common type of pancreatic cancer — may depend in part on how tense their tumors are.
-
Archive: Scientists ID Gene Behind Rare Childhood Syndrome
In a study of 10 children published online in the American Journal of Human Genetics on April 14, the researchers linked a constellation of birth defects affecting the brain, eye, ear, heart and kidney to mutations in a single gene, called RERE.
-
Archive: UCSF Immunologist to Head New Parker Institute for Cancer Immunotherapy
Renowned UCSF immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, established by Silicon Valley entrepreneur Sean Parker.